SCHEMBL8227585

SCHEMBL8227585

COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(C)nc3)NC(=O)NC1=O)C2

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12860563 0.93 ADAM17 (0.80) ADAM17
SCHEMBL12878377 0.87 ADAM17 (0.82) ADAM17
SCHEMBL13218730 0.87 ADAM17 (0.82) ADAM17
SCHEMBL8234487 0.87 ADAM17 (0.69) ADAM17
SCHEMBL12860703 0.86 ADAM17 (0.83) ADAM17
SCHEMBL6009435 0.86 ADAM17 (0.80) ADAM17
SCHEMBL10131348 0.85 ADAM17 (0.83) ADAM17
SCHEMBL10131390 0.85 ADAM17 (0.83) ADAM17
SCHEMBL12860464 0.85 ADAM17 (0.78) ADAM17
SCHEMBL12862444 0.85 ADAM17 (0.78) ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007084451-A1 HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2007-07-26 WO disclosed